Home › Proteinuria › Colorado
Pag-aaral pangklinika para sa Proteinuria sa Colorado
8 pag-aaral para sa Proteinuria ang naghahanap ng mga kalahok sa mga site sa Colorado.
Mga Lungsod sa Colorado
Opisyal na teksto ng pag-aaral (English)
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- University of Colorado Denver, Aurora
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT05268289A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #13, Arvada
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07268638A Study of JADE101 in Participants With Immunoglobulin A Nephropathy
- Jade Clinical Site, Arvada
- Jade Clinical Site, Denver
Nagre-recruitPhase 2
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07541287Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- Childrens Hospital Colorado, Aurora
Nagre-recruitPhase 3
Edad 2 hanggang 18 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06994845A Study to Assess the Effects of Zigakibart on IgA Nephropathy.
- Colorado Kidney Care Nephrology, Denver
Nagre-recruitPhase 2
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT07146906Study of Ravulizumab in Pediatric Participants With Primary IgAN
- Research Site, Aurora
Nagre-recruitPhase 3
Edad 2 hanggang 18 · Lahat ng kasarian · Na-update Hul 30, 2026 · NCT07024563Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
- Childrens Hospital Colorado, Aurora
Nagre-recruitPhase 3
Edad 12 hanggang 60 · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT05755386Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
- Childrens Hospital Colorado, Aurora
Nagre-recruitPhase 3
Edad 12 hanggang 60 · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04817618Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.